2:03 AM
 | 
Dec 07, 2017
 |  BC Extra  |  Financial News

Metacrine raises $22M series B

Chronic disease company Metacrine Inc. (San Diego, Calif.) raised $22 million in a series B round led by new investor New Enterprise Associates. Existing investors Arch Venture Partners, Polaris, venBio and Alexandria Venture Investments also participated.

Metacrine's lead...

Read the full 167 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >